Bioengineered Artificial Skin Market
According to Intent Market Research, the Bioengineered Artificial Skin Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 17.4% to touch USD 8.5 billion by 2030. The Bioengineered Artificial Skin Market is dominated by key players such as Organovo Holdings, Inc., Smith & Nephew Plc, Integra LifeSciences Holdings Corporation, Avita Medical, Mimetis Biomaterials, Acelity L.P. (KCI), Medtronic, Proteus Digital Health, 3D Systems, Synthekine, Cellular Dynamics International (Fujifilm), Epistem Ltd., Teijin Limited, Soluble Therapeutics, Hybrigenics.